Frontlight ResearchEarly access
Trial site
Atlanta Neuroscience Institute
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis8 trials
- Alzheimer disease1 trial
- Parkinson disease1 trial
- Phase
- Phase 35 trials
- Phase 42 trials
- Early phase 11 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.2 trials
- Genentech, Inc.2 trials
- Novartis Pharmaceuticals2 trials
- AriBio Co., Ltd.1 trial
- Cerevance1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
Active, not recruiting
Active, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026